About Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma is a company based in Osaka (Japan) founded in 1897.. Sumitomo Dainippon Pharma has completed 4 acquisitions, including Boston Biomedical, Sepracor and Sunovion. Sumitomo Dainippon Pharma operates in a competitive market with competitors including Annexon, Syndax, Clovis Oncology, Auron Therapeutics and C4X Discovery, among others.
- Headquarter Osaka, Japan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Boston Biomedical
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Sumitomo Dainippon Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Boston Biomedical, Sepracor and Sunovion. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for cancer and blood disorders are developed.
|
2011 | ||||
|
Develops novel therapeutics for treatment of cancer
|
2006 | ||||
|
Pharmaceutical products for respiratory and CNS disorders are developed.
|
1984 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sumitomo Dainippon Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sumitomo Dainippon Pharma Comparisons
Competitors of Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Syndax, Clovis Oncology, Auron Therapeutics and C4X Discovery, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Targeted therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative immunotherapy drugs for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of cancer therapeutics for the treatment of blood cancer
|
|
| domain | founded_year | HQ Location |
Developer of optimized drug discovery and design services
|
|
| domain | founded_year | HQ Location |
Personalized cell-based autologous therapies for anti-tumor applications are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sumitomo Dainippon Pharma
Frequently Asked Questions about Sumitomo Dainippon Pharma
When was Sumitomo Dainippon Pharma founded?
Sumitomo Dainippon Pharma was founded in 1897.
Where is Sumitomo Dainippon Pharma located?
Sumitomo Dainippon Pharma is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
What does Sumitomo Dainippon Pharma do?
Sumitomo Dainippon Pharma was founded in 1897 and is headquartered in Osaka, Japan. Operations focus on the pharmaceutical sector, where 11 products are developed for therapeutic areas including hypertension, Parkinsons disease, and antifungal treatments. Additional activities encompass the production of food ingredients, food additives, and veterinary products, supporting diverse markets in healthcare and nutrition.
Who are the top competitors of Sumitomo Dainippon Pharma?
Sumitomo Dainippon Pharma's top competitors include Syndax, iTeos Therapeutics and Annexon.
How many acquisitions has Sumitomo Dainippon Pharma made?
Sumitomo Dainippon Pharma has made 4 acquisitions, including Boston Biomedical, Sepracor, and Sunovion.